相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer
Manuela Eppenberger et al.
BMC CANCER (2010)
Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
Hugo M. Horlings et al.
CLINICAL CANCER RESEARCH (2010)
Role of the Serrated Pathway in Colorectal Cancer Pathogenesis
Barbara Leggett et al.
GASTROENTEROLOGY (2010)
Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome
Valeria Barresi et al.
VIRCHOWS ARCHIV (2010)
Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology
Lee M. Ellis et al.
CLINICAL CANCER RESEARCH (2009)
Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor-Targeted Therapy in Metastatic Colorectal Cancer
Salvatore Siena et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors
Lokesh Jain et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer
F. R. Hirsch et al.
ONCOGENE (2009)
Genetic prognostic and predictive markers in colorectal cancer
Axel Walther et al.
NATURE REVIEWS CANCER (2009)
Molecular classification and correlates in colorectal cancer
Shuji Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Targeted therapy of cancer: new roles for pathologists in colorectal cancer
Stanley R. Hamilton
MODERN PATHOLOGY (2008)
Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells
Nikolaos A. Dallas et al.
CANCER AND METASTASIS REVIEWS (2007)
Genomic copy-number aberrations related to lymph-node metastasis of colon cancer
Y. Yaginuma et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2006)
A new approach to the validation of tissue microarrays
L Goethals et al.
JOURNAL OF PATHOLOGY (2006)
Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizurnab in metastatic colorectal cancer
AM Jubb et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy
Jordi Giralt et al.
ONCOLOGY (2006)
A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods
I Zlobec et al.
CLINICAL CANCER RESEARCH (2005)
The MAPK signalling pathways and colorectal cancer
JY Fang et al.
LANCET ONCOLOGY (2005)
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Association of VEGF genotype with mRNA level in colorectal adenocarcinomas
M Yamamori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression
V Hanrahan et al.
JOURNAL OF PATHOLOGY (2003)